DKSH Australia provides laboratories across the country with scientific instruments, test kits and consumables to battle COVID-19. This initiative is in line with the strategy of DKSH Business Unit Technology to focus on growing and value-adding segments.
Media release
Melbourne, Australia, January 27, 2021 – DKSH Business Unit Technology, a leading Market Expansion Services provider for technology companies seeking to grow their business in Asia Pacific, continues to support Australia with effective and reliable scientific instrumentation and solutions to combat COVID-19.
Since the wake of the pandemic, DKSH Australia has and continues to offer a comprehensive range of scientific instruments, test kits and consumables to laboratories across the country. The equipment is used for the prevention, sampling, detection and vaccine development for SARS-CoV-2 – the virus that causes COVID-19. The product range includes:
- Personal protective equipment, such as facemasks and gloves
- Nasopharyngeal swabs and media for sample collection and transportation
- Two kinds of COVID-19 test kits:
– A diagnostic molecular test kit
– An antibody test kit - Two types of analysers used to detect COVID-19:
– Techne Prime Pro 48 Real-Time PCR System used for the diagnostic molecular test.
– Virion Serion Immunomat™ ELISA Analyser used for the detection of antibodies. - Cell culture analysers (Nova Biomedical Flex 2) and general laboratory equipment, such as shakers and stirrers used for vaccine production.
“We are proud to work with the Australian scientific industry to help prevent the spread of COVID-19, by providing a comprehensive range of products,” commented Murray McCullough, Manager, Scientific Instrumentation, DKSH Australia. “We are particularly grateful to our committed team that works hard to ensure that supply of critical equipment and reagents used in vaccine production are not affected”.
For further information, please contact:
DKSH Australia Pty. Ltd.
Tina Thai
Specialist, Branding & Communications
+61 481 964 137
tina.thai@dksh.com
About DKSH
DKSH is the leading Market Expansion Services provider with a focus on Asia. The Group helps companies to grow across the Business Units Healthcare, Consumer Goods, Performance Materials and Technology. The service portfolio covers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. Publicly listed on the SIX Swiss Exchange, the Group operates in 36 markets with 33,350 specialists, generating net sales of CHF 11.6 billion in 2019. With its Swiss heritage, DKSH has been deeply rooted in Asia Pacific since 1865. The DKSH Business Unit Technology offers complete solutions for specialized industrial applications. With around 1,670 specialists, the Business Unit generated net sales of CHF 431.9 million in 2019.